Core Viewpoint - The major shareholder of Shandong Keyuan Pharmaceutical Co., Ltd., Mr. Wen Zehong, plans to reduce his shareholding by up to 3,248,700 shares, which accounts for 3.00% of the company's total share capital, through centralized bidding and block trading methods [1][2]. Group 1: Shareholder Information - Mr. Wen Zehong holds 8,400,000 shares, representing 7.76% of the company's total share capital [1]. - The planned reduction includes a maximum of 1,082,900 shares (1.00% of total share capital) through centralized bidding and up to 2,165,800 shares (2.00% of total share capital) through block trading [1][2]. Group 2: Reduction Plan Details - The reduction will occur within three months after the announcement, starting fifteen trading days from the date of the announcement [1][2]. - The total number of shares to be reduced through centralized bidding and block trading is capped at 3,248,700 shares [1][2]. Group 3: Shareholder Commitments - Mr. Wen made commitments regarding shareholding restrictions prior to the company's initial public offering, including a 36-month lock-up period for shares acquired before the IPO and a 12-month lock-up period for shares issued during the IPO [2][3]. - If Mr. Wen violates these commitments, any proceeds from unauthorized share reductions will belong to the company, and the company has the right to withhold dividends to recover the amounts [3][4].
科源制药: 关于持股5%以上股东股份减持计划的预披露公告